Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results

Bulletin Express

03/10

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.

The current Board configuration is as follows: • Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong • Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing

The company released the meeting notice on 10 March 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1123900438"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123900438\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123900438?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123900438","market":"us","top_or_hot":-1,"title":"Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results","media":"Bulletin Express","content":"<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.</p>\n<p>The current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing</p>\n<p>The company released the meeting notice on 10 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-10 16:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.</p>\n<p>The current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing</p>\n<p>The company released the meeting notice on 10 March 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白雲山","start_time":0,"source_url":"","article_id":"1123900438","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123900438","pubTimestamp":1773132196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00874":"白云山"},"translate_title":"白云山药业(00874)定于2026年3月20日召开董事会批准2025财年经审核业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00874":1},"content_text":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (H share stock code: 00874) has scheduled a board meeting for Friday, 20 March 2026 in Guangzhou. The agenda includes consideration and approval of the audited consolidated financial results for the year ended 31 December 2025, along with any other relevant business.\nThe current Board configuration is as follows:\n• Executive directors: Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong  \n• Independent non-executive directors: Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing\nThe company released the meeting notice on 10 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}